New 'Off-the-Shelf' cell therapy tested in patients who have run out of options
Disease control
Completed
This early-stage study tested a new, lab-made cell therapy called FT576 in patients with multiple myeloma that had returned or stopped responding to standard treatments. The main goals were to find a safe dose and see if the treatment, given alone or with an existing drug (daratu…
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC